Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sergei V. Tsarenko"'
Publikováno v:
Biosensors, Vol 13, Iss 3, p 343 (2023)
Tigecycline (TGC), a third-generation tetracycline, is characterized by a more potent and broad antibacterial activity, and the ability to overcome different mechanisms of tetracycline resistance. TGC has proven to be of value in treatment of multidr
Externí odkaz:
https://doaj.org/article/e6e381b876204e8ba852214fd69c499d
Autor:
Yury A. SUROVOY, Maksim A. BURKIN, Inna A. GALVIDIS, Mikhail A. SOBOLEV, Onur Can RENDE, Sergei V. TSARENKO
Publikováno v:
European Journal of Clinical Pharmacology. 79:79-87
The aim of this study was to assess polymyxin B pharmacokinetics (PK) in patients with varying degrees of renal dysfunction and in patients, who require continuous veno-venous hemodialysis (CVVHD). The study enrolled 37 patients with sepsis, among wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a53e9a5c9f50030301300847b9a3a63
https://doi.org/10.1007/s00228-022-03415-x
https://doi.org/10.1007/s00228-022-03415-x
Autor:
Yury A, Surovoy, Maksim A, Burkin, Inna A, Galvidis, Pavel O, Bochkov, Armen V, Oganesyan, Sergei V, Tsarenko
Publikováno v:
Journal of Antimicrobial Chemotherapy. 77:1379-1384
Objectives To describe polymyxin B pharmacokinetics in patients receiving veno-venous extracorporeal membrane oxygenation (ECMO) in comparison with critically ill patients without ECMO support and to explore potential covariates that could affect the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76379304541c59d3fc7df0e5a6b87532
https://doi.org/10.1093/jac/dkac021
https://doi.org/10.1093/jac/dkac021
Autor:
Alexey A. Martyanov, Anna E. Boldova, Maria G. Stepanyan, Olga I. An, Alexander S. Gur'ev, Darya V. Kassina, Alexey Y. Volkov, Alexandr V. Balatskiy, Andrei A. Butylin, Sergei S. Karamzin, Elena V. Filimonova, Sergei V. Tsarenko, Sergei A. Roumiantsev, Alexander G. Rumyantsev, Mikhail A. Panteleev, Fazoil I. Ataullakhanov, Anastasia N. Sveshnikova
Publikováno v:
Thrombosis Research
Introduction Defects of platelet functional responses in COVID-19 were reported, but their origin and pathophysiological significance are unclear. The objective of this study was to characterize the thrombocytopathy in COVID-19. Materials and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09171bc1034192e225b611aa23b08352
https://pubmed.ncbi.nlm.nih.gov/35066204
https://pubmed.ncbi.nlm.nih.gov/35066204
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 220:114983
Polymyxins are increasingly used to treat multidrug resistant bacteria in critically ill patients, however these drugs have a narrow therapeutic window. Highly variable antibiotic pharmacokinetics in critically ill patients puts them at high risks of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daf6d3e4c5a8de87999c71f8e0ae80e7
https://doi.org/10.1016/j.jpba.2022.114983
https://doi.org/10.1016/j.jpba.2022.114983
Autor:
Igor A. Rodin, Inna A. Galvidis, Maksim A. Burkin, Sergei V. Tsarenko, I. V. Plyushchenko, Yuri A. Surovoy
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 204
Treating infections in critically ill patients often requires the use of last-line antibacterial drugs such as polymyxins with a narrow therapeutic window and high toxicity. In critically ill patients, the drug pharmacokinetics changes significantly,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcb301611d1601c49b0809bf26b2987d
https://pubmed.ncbi.nlm.nih.gov/34311285
https://pubmed.ncbi.nlm.nih.gov/34311285